Recent Finacing
Recent Raise
Arrakis develops small-molecule therapeutics targeting RNA, using TRYST and PEARL-seq discovery platforms to identify RNA targets and matching binders, advancing therapeutics for genetically driven neurologic, oncologic, and rare diseases.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors